The bitter truth
In Bottle of Lies: Ranbaxy and The Dark Side of Indian Pharma, Author Katherine Eban investigates the fall of Ranbaxy — a doom of its own making
September 27, 2019
The Eclipse of A Star
Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market
Prathamesh Mulye - March 25, 2019
"No matter how sincere your efforts though, the competition will never let go of things easily"
Secret Diary of Ajay Piramal — Part 2
N Mahalakshmi - May 04, 2018
Homesick
Rising chronic illnesses and increasing health insurance coverage will spur domestic pharma industry growth
January 02, 2018
Early Mover
What makes Intas the most valuable privately-held pharma company in India
Krishna Gopalan - June 09, 2017
Master Innovator
Vishnukant Bhutada’s big bet on oncology has catapulted Shilpa Medicare into the global generics space
Shilpa Elizabeth Abraham - June 09, 2017
Selling in tango
Fortis Healthcare promoters are unlocking some value on their own
Khushboo Balani - June 20, 2017
Niraj Dalal
Sun Pharma has a robust pipeline in specialty business which will drive its profitability and free cash flow in the near future
January 13, 2017
Growth eclipse
After a dream run, Sun Pharma is grappling with growth and regulatory issues. Can the country’s biggest drug maker rediscover its mojo?
Krishna Gopalan - January 22, 2016
If you've got it, <br> flaunt it </br>
Pharma companies are giving OTC brands a makeover by splurging on advertising
Himanshu Kakkar - September 29, 2015
